Where I see patients (2)
Selected research
-
CT-P17 Adalimumab Biosimilar in Patients with Moderate-to-Severe Chronic Plaque Psoriasis: An Open-Label Extension of a Phase 3 Interchangeability Study.
Dermatology and therapy
-
Can pimozide kill parasites? Surprisingly, the most honest answer is 'yes'.
The Journal of dermatological treatment
-
Repeated Switching Between CT-P17 and EU Reference Adalimumab in Patients with Moderate-to-Severe Chronic Plaque Psoriasis: A Randomized, Double-Blind, Active-Controlled, Phase 3, Interchangeability Study.
Advances in therapy